Roth Capital Downgrades CorMedix (CRMD) to Neutral
Tweet
Share
E-mailGet Alerts CRMD Hot Sheet
Price: $8.75 --0%
Rating Summary:
10 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 15 | Down: 23 | New: 30
Rating Summary:
10 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 15 | Down: 23 | New: 30
Join SI Premium – FREE
Roth Capital downgraded CorMedix (NYSE: CRMD) from Buy to Neutral with a price target of $7.50 (from $2.50).
For an analyst ratings summary and ratings history on CorMedix click here. For more ratings news on CorMedix click here.
Shares of CorMedix closed at $7.60 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Morgan Stanley Downgrades Seven & i Holdings Co Ltd (3382:JP) (SVNDF) to Equalweight, Earnings US May Peak F2/27
- ICICI Bank (ICICIBC:IN) (IBN) PT Raised to INR1,600 at BofA Securities
- Prada SpA (1913:HK) (PRDSY) PT Lowered to HK$45 at Bernstein SocGen Group
Create E-mail Alert Related Categories
Analyst PT Change, DowngradesRelated Entities
Roth CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
